Localization of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland.

J J Gomm, Joseph M. Smith, G K Ryall, Rebecca Baillie, L Turnbull, R. Charles Coombes

PubMed · 1991 · 123 citations · 58 references

Concepts

TL;DR

The relative localization of bFGF and TGF‑β1 in the mammary gland may influence breast development and tumor progression. The study mapped bFGF and TGF‑β1 distribution in benign and malignant breast tissues using immunohistochemistry and immunoblotting. bFGF was confined to myoepithelial cells in benign breast and only detected in malignant samples when benign elements remained, whereas TGF‑β1 was consistently found in periductal and intraductal stroma adjacent to epithelial or myoepithelial cells.

Abstract

The presence and distribution of basic fibroblast growth factor (bFGF) and transforming growth factor beta 1 in benign and malignant human breast tissue were determined by immunohistochemistry and immunoblotting. Peroxidase staining of biopsy specimens using a polyclonal antibody to amino acids 1-24 of bFGF and a monoclonal antibody to whole recombinant bFGF showed this growth factor to be localized in the myoepithelial cells of the benign breast. Epithelial cells and stroma were negative. In hyperplasia and intraductal carcinoma in situ staining was still seen around the perimeter of enlarged ducts. In malignant biopsies, however, staining was seen only when benign elements were present or residual myoepithelial cells and basement membrane remained. Antigen absorption and immunoblotting confirmed the antibody staining to be specific for bFGF. Transforming growth factor beta 1 was shown, using the same techniques, to be located in the periductal and intraductal stroma, closely associated with epithelial or myoepithelial cells in the benign and malignant breast. The relative localization of these two growth factors in the mammary gland may be significant in the control of breast development and/or tumor formation and progression.

References

58